Cargando…
Decreased serum phosphate levels are a useful biomarker to predict occurrence and severity of cytokine release syndrome in chimeric antigen receptor T‐cell therapy
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092564/ https://www.ncbi.nlm.nih.gov/pubmed/36220156 http://dx.doi.org/10.1111/bjh.18504 |
| _version_ | 1785023375843786752 |
|---|---|
| author | Nakamura, Naokazu Arai, Yasuyuki Kitawaki, Toshio Jo, Tomoyasu Mizumoto, Chisaki Kanda, Junya Nishikori, Momoko Yamashita, Kouhei Takaori‐Kondo, Akifumi |
| author_facet | Nakamura, Naokazu Arai, Yasuyuki Kitawaki, Toshio Jo, Tomoyasu Mizumoto, Chisaki Kanda, Junya Nishikori, Momoko Yamashita, Kouhei Takaori‐Kondo, Akifumi |
| author_sort | Nakamura, Naokazu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10092564 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100925642023-04-13 Decreased serum phosphate levels are a useful biomarker to predict occurrence and severity of cytokine release syndrome in chimeric antigen receptor T‐cell therapy Nakamura, Naokazu Arai, Yasuyuki Kitawaki, Toshio Jo, Tomoyasu Mizumoto, Chisaki Kanda, Junya Nishikori, Momoko Yamashita, Kouhei Takaori‐Kondo, Akifumi Br J Haematol Letters to the Editor–Online Only John Wiley and Sons Inc. 2022-10-11 2023-01 /pmc/articles/PMC10092564/ /pubmed/36220156 http://dx.doi.org/10.1111/bjh.18504 Text en © 2022 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letters to the Editor–Online Only Nakamura, Naokazu Arai, Yasuyuki Kitawaki, Toshio Jo, Tomoyasu Mizumoto, Chisaki Kanda, Junya Nishikori, Momoko Yamashita, Kouhei Takaori‐Kondo, Akifumi Decreased serum phosphate levels are a useful biomarker to predict occurrence and severity of cytokine release syndrome in chimeric antigen receptor T‐cell therapy |
| title | Decreased serum phosphate levels are a useful biomarker to predict occurrence and severity of cytokine release syndrome in chimeric antigen receptor T‐cell therapy |
| title_full | Decreased serum phosphate levels are a useful biomarker to predict occurrence and severity of cytokine release syndrome in chimeric antigen receptor T‐cell therapy |
| title_fullStr | Decreased serum phosphate levels are a useful biomarker to predict occurrence and severity of cytokine release syndrome in chimeric antigen receptor T‐cell therapy |
| title_full_unstemmed | Decreased serum phosphate levels are a useful biomarker to predict occurrence and severity of cytokine release syndrome in chimeric antigen receptor T‐cell therapy |
| title_short | Decreased serum phosphate levels are a useful biomarker to predict occurrence and severity of cytokine release syndrome in chimeric antigen receptor T‐cell therapy |
| title_sort | decreased serum phosphate levels are a useful biomarker to predict occurrence and severity of cytokine release syndrome in chimeric antigen receptor t‐cell therapy |
| topic | Letters to the Editor–Online Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092564/ https://www.ncbi.nlm.nih.gov/pubmed/36220156 http://dx.doi.org/10.1111/bjh.18504 |
| work_keys_str_mv | AT nakamuranaokazu decreasedserumphosphatelevelsareausefulbiomarkertopredictoccurrenceandseverityofcytokinereleasesyndromeinchimericantigenreceptortcelltherapy AT araiyasuyuki decreasedserumphosphatelevelsareausefulbiomarkertopredictoccurrenceandseverityofcytokinereleasesyndromeinchimericantigenreceptortcelltherapy AT kitawakitoshio decreasedserumphosphatelevelsareausefulbiomarkertopredictoccurrenceandseverityofcytokinereleasesyndromeinchimericantigenreceptortcelltherapy AT jotomoyasu decreasedserumphosphatelevelsareausefulbiomarkertopredictoccurrenceandseverityofcytokinereleasesyndromeinchimericantigenreceptortcelltherapy AT mizumotochisaki decreasedserumphosphatelevelsareausefulbiomarkertopredictoccurrenceandseverityofcytokinereleasesyndromeinchimericantigenreceptortcelltherapy AT kandajunya decreasedserumphosphatelevelsareausefulbiomarkertopredictoccurrenceandseverityofcytokinereleasesyndromeinchimericantigenreceptortcelltherapy AT nishikorimomoko decreasedserumphosphatelevelsareausefulbiomarkertopredictoccurrenceandseverityofcytokinereleasesyndromeinchimericantigenreceptortcelltherapy AT yamashitakouhei decreasedserumphosphatelevelsareausefulbiomarkertopredictoccurrenceandseverityofcytokinereleasesyndromeinchimericantigenreceptortcelltherapy AT takaorikondoakifumi decreasedserumphosphatelevelsareausefulbiomarkertopredictoccurrenceandseverityofcytokinereleasesyndromeinchimericantigenreceptortcelltherapy |